Navigation Links
Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2008 Financial Results
Date:11/10/2008

September 30, September 30,

(unaudited) (unaudited)

2008 2007 2008 2007

REVENUE:

License revenue $327 $41 $853 $41

Service revenue 41 11 103 37

TOTAL REVENUE 368 52 956 78

OPERATING EXPENSES:

Cost of services 13 28 27 90

Research and development:

Non-cash compensation 334 735 (395) 2,908

Other research and

development 2,208 15,965 37,277 49,093

Total research and

development 2,542 16,700 36,882 52,001

Selling, general and administrative:

Non-cash compensation 1,662 1,780 5,146 5,193

Other selling, general

and administrative 2,284 2,062 6,249 6,531

Total selling,

general and

administrative 3,946 3,842 11,395 11,724

TOTAL OPERATING EXPENSES 6,501 20,570 48,304 63,815

OPERATING LOSS (6,133) (20,518) (47,348) (63,737)

OTHER INCOME:

Interest and other

(expense) income, net (622) 1,017 (1,551) 3,658

LOSS FROM CONTINUING

OPERATIONS (6,755) (19,501) (48,899) (60,079)

Loss from discontinued

operations (86) (27) (175) (722)

NET LOSS $(6,841) $(19,528) $(49,074) $(60,801)

NET LOSS PER COMMON

SHARE

Continuing

operations $(0.15) $(0.45) $(1.11) $(1.38)

Discontinued

operations $(--) * $(--) * $(--) *
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Keryx Biopharmaceuticals KRX-0401 (Perifosine) Data Selected for Oral Presentation at the 50th Annual Meeting of the American Society of Hematology
2. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2008 Financial Results on Tuesday, November 11, at 8:30 A.M. EST
3. Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2008 Financial Results
4. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) to be Presented at the Upcoming American Society of Hematology Meeting in Atlanta, Georgia
5. Presentation Time Correction: Keryx Biopharmaceuticals Presents at 12:00pm, ET Tomorrow (Oct. 3) at William Blair & Company Small-Cap Growth Stock Conference
6. Transition Therapeutics Announces First Quarter Fiscal 2009 Financial Results
7. Bradmer announces 2008 third quarter operational and financial results
8. Hillenbrand, Inc. Announces Fourth-Quarter Earnings Release Date and Conference Call
9. TransTech Services Partners Inc. Announces Election of Dr. Ranga C. Krishna as a Director
10. URAC Announces Finalists for Best Practices in Health Care Consumer Empowerment and Protection Awards
11. Heska Announces Q3 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... York (PRWEB) January 22, 2015 The federal ... in the U.S. District Court, Southern District of West Virginia ... Inc. in that proceeding’s first bellwether trial. In an Order ... a new trial after finding that C.R. Bard had not ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Autocarinsurancebest.com has released ... purchasing a commercial auto insurance policy . , Auto ... their vehicles. It is no longer necessary to call an ... are now available online on a single website: http://autocarinsurancebest.com/ ...
(Date:1/22/2015)... New York, NY (PRWEB) January 22, 2015 ... American College of Sports Medicine flagship journal Medicine ... supplementation with L-Citrulline before exercise may help reduce ... strenuous exercise. 1 , Participants in the ...
(Date:1/22/2015)... Four years since the release of their debut recording Love ... of Avasa & Matthew Love – the duo are pleased to ... through White Swan Records on February 24, 2015. , THE ROAD ... available to all of us to walk out of the mire ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 JJsHouse.com is a ... dresses. Today, the business announces its latest collection of ... , “The most important issue is the wedding dress on ... thing in a woman’s life. Every bride wants to find ...
Breaking Medicine News(10 mins):Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2
... use has been found to contribute to gum disease, apart ... to have. , In a group of more than 900 ... since age 18 was found to be responsible for more ... ages 26 and 32, according to a study published Feb. ...
... finds, , , TUESDAY, Feb. 5 (HealthDay News) -- Pot smokers ... do, such as an increased risk of heart disease, but ... destroy gum tissue. , In the Feb. 6 issue ... researchers reported that heavy marijuana users have as much as ...
... thousands of studies ... benefits of therapeutic lasers, FORT COLLINS, Colo., Feb. ... of the company, and the availability of,professional-grade therapeutic laser ... hand therapists, and more),as well as consumer-grade therapeutic laser ...
... HMS Holdings Corp. (Nasdaq:,HMSY) today announced that it will ... will be held February 11-13, 2008 at,the Grand Hyatt ... President and Chief Financial Officer of HMS,Holdings Corp., will ... A live broadcast of the Company,s presentation can ...
... SAFE IN THE SUN, ... CAMPAIGN, ... of the L,Oreal Group, announced that they have granted the,Women,s Dermatologic Society ... in the Sun campaign, effective April,2008. The WDS educational outreach campaign focuses ...
... high amounts of whole grains may help achieve significant ... diseases such as diabetes and cardiovascular disease, according to ... and the College of Medicine., "Consumption of whole grains ... lower blood pressure," said co-author Penny Kris-Etherton, distinguished professor ...
Cached Medicine News:Health News:Marijuana Bad for the Gums 2Health News:Marijuana Bad for the Gums 3Health News:Integrated Laser Therapies Launches, Offers Low-power, Therapeutic Laser Devices and Training for Therapists and Consumers 2Health News:L'Oreal USA Announces Three-Year Support of Women's Dermatologic Society Foundation Community Outreach 2Health News:L'Oreal USA Announces Three-Year Support of Women's Dermatologic Society Foundation Community Outreach 3Health News:Whole grain diets lower risk of chronic disease 2Health News:Whole grain diets lower risk of chronic disease 3
(Date:1/23/2015)... Tianyin Pharmaceutical Inc. (NYSE Amex: TPI ... and sale of patented biopharmaceutical medicine, modernized traditional Chinese ... today announced the business and development progress at its ... Following the September 2014 JCM application (No. 51268) for ...
(Date:1/22/2015)... , Jan. 22, 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; ... a focus on Omega-3 therapies for cardiovascular disease and overall ... the Company,s accomplishments in 2014 and its outlook for 2015 ... Dear Fellow Shareholders, We would like to take ...
(Date:1/22/2015)... DUBLIN , Jan. 22, 2015 Research and Markets ... of the "Infectious Disease Diagnostics Market by Product, ... report to their offering. , The ... CAGR of 7.9% to reach $18,156.2 million by 2019 ...
Breaking Medicine Technology:TPI's JCM Updates on Import Registration for International Clients 2TPI's JCM Updates on Import Registration for International Clients 3TPI's JCM Updates on Import Registration for International Clients 4Pivotal Therapeutics: Year in Review and CEO Update 2Pivotal Therapeutics: Year in Review and CEO Update 3Pivotal Therapeutics: Year in Review and CEO Update 4Pivotal Therapeutics: Year in Review and CEO Update 5Pivotal Therapeutics: Year in Review and CEO Update 6Pivotal Therapeutics: Year in Review and CEO Update 7Global Infectious Disease Diagnostics (Instruments, Reagents, Services, Software) Market - Forecast to 2019 2Global Infectious Disease Diagnostics (Instruments, Reagents, Services, Software) Market - Forecast to 2019 3
... Feb. 9, 2011 GeoVax Labs, Inc. (OTC Bulletin ... develops and tests innovative HIV/AIDS vaccines, announced today the ... Alabama Vaccine Research Clinic (AVRC) of the University of ... therapeutic vaccine trial. Although the GeoVax vaccines are currently ...
... The Covaris® LE220™ high performance ultra-sonicator has received ... at the LabAutomation 2011 conference in Palm Springs ... laboratory automation conference and exhibition, bringing science, technology, and ... LabAutomation are evaluated by a team of industry experts. ...
Cached Medicine Technology:GeoVax Launches a Second Clinical Site to Test the Therapeutic Benefit of its HIV Vaccine 2GeoVax Launches a Second Clinical Site to Test the Therapeutic Benefit of its HIV Vaccine 3Covaris Receives the Society for Laboratory Automation and Screening (SLAS) New Product Award at LabAutomation 2011 2
The original, and now classic, Bard mesh sheet can be tailored perioperatively and customized to any unique situation. Bard mesh sheets are available in seven convenient sizes....
... is constructed of Bard polypropylene mesh, the ... 40 years. Developed with the world renowned ... Mesh takes the guesswork out of sizing ... performs a Lichtenstein inguinal hernia repair procedure.,Its ...
... is a minimally invasive, tension-free technique that ... cm incision and requires minimal suturing. It ... open, anterior approach that can be completed ... patch is a self-expanding polypropylene patch that ...
... The Bard PerFix plug technique, recommended ... and recurrent indirect and direct inguinal ... conventional suture technique, requiring less overall ... complete tension-free repair technique. The result ...
Medicine Products: